跳至主要内容
临床试验/JPRN-jRCTs052210098
JPRN-jRCTs052210098已完成未知

Safety and efficacy of the stabilizer device using in endovascular therapy for cerebral aneurysm

sakai nobuyuki0 个研究点目标入组 5 人开始时间: 2021年10月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

Primary endpoint, defined hemorrhagic complication, did not occur because the trial device was stable without unexpected movements. Secondary endpoint for safety, defined 1; ischemic stroke, 2; arterial dissection, 3; vasospasm, did not occur. 4; other adverse event, transient finger fine movement disturbance occurred just after treatment in 1 case, but disappeared spontaneously and no ischemic change on MRI at next day of treatment. This even is not related to device and treatment.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1)Patients who are scheduled to have a flow divertor or coil-assisted stent for cerebral aneurysm
  • 2) Patients who are expected to have difficulty delivering the catheter to the treatment site.
  • 3)Patients aged between 20years and 80years old at the time of concent acquisition
  • 4)Patients who consented to the study in writing

排除标准

  • 1)A history of hypersensitivity to nickel or titanium
  • 2)A patient who is judged by the principal investigator to be inappropriate in this study

研究者

发起方
sakai nobuyuki

相似试验